Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin vs Tamsulosin Ocular Effects in BPH
NCT03144596Phase 4Completed
- Sponsor
- Afyon Kocatepe University
- Start
- Oct 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of alfuzosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Afyon Kocatepe University. Primary endpoints: Change from baseline choroidal thicknesses at 3 months and Change from baseline pupil diameter sizes at 3 months. Started Oct 2015; status: completed.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT03144596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03144596.